Featured posts

Latest posts

What’s new in Opcenter Scheduling SMT 16.1

Get started quickly with improved integration to ASM SIPLACE Pro In PCB assembly manufacturing, work order modifications, time overruns, and…

What’s new in Opcenter Quality version 12.4

Empowering quality inspection tools to detect any potential deviations on products and processes We are excited to announce the availability…

Miba drive train component manufacturer uses Opcenter Quality software to minimize tolerances while reducing machining time.

Streamlining quality assurance to pursue zero-defects initiative

Siemens Digital Industries Software solution helps Miba streamline global quality assurance work in pursuit of zero-defects initiative.

Formulating a successful digital transformation

Siemens has identified some key ingredients common to the many successful digital transformations we have helped implement.

What’s new in Opcenter Execution Pharma version 6.2.4

Providing a paperless solution for the life sciences/pharma industries! We are excited to announce that the latest version Opcenter™ Execution…

AVAILABLE NOW! Opcenter Execution Process 4.2

A new version of our MES for Process Industries is available: Opcenter Execution Process 4.2. Opcenter Execution Process 4.2, which…

The impact of new European Medical Device regulations

The New Regulation (EU) 2017/745 for medical devices (MDRs), which went into effect on May 26, 2021, is a major update to the regulatory framework in the European Union (EU).

Image of a lights out factory feature an automated production line

Factories of Future: Data driven and towards lights-out processes

The data-driven, lights-out factory of the future promises to bring new efficiencies and higher product quality. The success of new lights-out factories is inspiring, but what prerequisites are needed to help manufacturers on their journey?

Ask the Expert: Leveraging the Digital Infrastructure to Accelerate Growth

Today’s disruptive market scenarios, the unknown consequences of COVID-19, increasingly sophisticated personalized, and the new FDA and EU Regulatory implications…